Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy

Raafat Abdel-Malek; Noha Abbas; Kyrillus S. Shohdy; Mohamed Ismail; Radwa Fawzy; Dalal S. Salem; Ezzat Safwat

doi:10.1016/j.jnci.2017.05.001

Q1 2017

Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy

Raafat Abdel-Malek · Noha Abbas · Kyrillus S. Shohdy · Mohamed Ismail · Radwa Fawzy · Dalal S. Salem · Ezzat Safwat

10.1016/j.jnci.2017.05.001 377 المشاهدات 8 الاقتباسات

الاقتباسات

377

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Raafat, A., Noha, A., Kyrillus, S. S., Mohamed, I., Radwa, F., Dalal, S. S., Ezzat, S. (2017). Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy. Journal of the Egyptian National Cancer Institute. https://doi.org/10.1016/j.jnci.2017.05.001

Supriya Mallick; Rony Benson; Abdul Hakim; Goura K. Rath · 2016

104

استشهاد

393

Management of glioblastoma after recurrence: A changing paradigm

Supriya Mallick; Rony Benson; Abdul Hakim; Goura K. Rath · 2016

104

استشهاد

390

Radiation induced liver disease: A clinical update

R. Benson; R. Madan; R. Kilambi; S. Chander · 2016

102